YY1 and rhabdomyosarcoma: In rhabdomyosarcoma on the other hand, there is epigenetic silencing of miRNA29 through activation of the NFKB-YY1 pathway and as a result there is reduced silencing of YY1 by miRNA 29, and in the context of higher YY1, myogenic differentiation does not progress [116].